🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 11 of 15

  1. US 8663705

    Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8652445

    Dental compositions with sensitivity relief

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8648072

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8632751

    Scanning suspension comprising a particle with a diameter of at least 1 micrometer

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8623867

    Cyclic amine BACE-1 inhibitors having a benzamide substituent

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8618110

    Compositions and methods for apoptosis modulators

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8613963

    Nutritional supplement

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8609706

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8592456

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8580768

    Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8562954

    Dental compositions with sensitivity relief

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8562955

    Light-activated tooth whitening method

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8546376

    Pharmaceutical compounds

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8541475

    MAO-B inhibitors useful for treating obesity

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8529885

    AAV vectors for in vivo gene therapy of rheumatoid arthritis

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8524194

    Radiolabelled MMP selective compounds

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8455010

    Product and method for producing an immune system supplement and performance enhancer

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8440679

    Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8435993

    Methods of inhibiting metastasis from cancer

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8431566

    Cyclopamine lactam analogs and methods of use thereof

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8426436

    Heterocyclic cyclopamine analogs and methods of use thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8410081

    Treatment of cystic fibrosis

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8367655

    Pyridoindolobenzox—and thiazepine derivatives and uses thereof

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8367120

    Method and apparatus for producing a stablized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8361743

    Biological production of zeaxanthin and carotenoid biosynthesis control

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8357676

    Ansamycin formulations and methods of use thereof

    Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8354436

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8337815

    Pulmonary surfactant formulations

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8334282

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8304428

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8303985

    Skin treatment compositions containing copper-pigment complexes

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8303984

    Skin treatment compositions containing copper-pigment complexes

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8298555

    Color cosmetic compositions for topical anti-aging skin treatment

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8293760

    Cyclopamine lactam analogs and methods of use thereof

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8252791

    Purine compounds as cannabinoid receptor blockers

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8252267

    DKKL-1 splice product modulators for cancer diagnosis and therapy

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8242112

    Heterocyclic aspartyl protease inhibitors

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8236784

    Composition comprising threitol phosphate and salts thereof

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8236821

    Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8227246

    Compositions of adult disc stem cells for the treatment of degenerative disc disease

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8227516

    Compounds as histone deacetylase inhibitors

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8221772

    Pulmonary surfactant formulations and methods for promoting mucus clearance

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8217038

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8207170

    Heterocyclic substituted piperazines with CXCR3 antagonist activity

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8178513

    Heterocyclic aspartyl protease inhibitors

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8148343

    Tumor suppressor factor

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8138216

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8133904

    Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.